HOOKIPA Pharma Inc. financial data

Symbol
HOOK on Nasdaq
Industry
Pharmaceutical Preparations
Location
350 Fifth Avenue, 72 Nd Floor, Suite 7240, New York, NY
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 376 % -2.08%
Debt-to-equity 58.8 % -8.5%
Return On Equity -51.8 % +21.9%
Return On Assets -32.6 % +19.3%
Operating Margin -124 % +74.8%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 71.7M USD -13.2%
Weighted Average Number of Shares Outstanding, Basic 12.5M shares +51.6%
Weighted Average Number of Shares Outstanding, Diluted 12.5M shares +51.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 52.2M USD +228%
Research and Development Expense 85.7M USD +12%
General and Administrative Expense 17.3M USD -4.53%
Costs and Expenses 117M USD +23.7%
Operating Income (Loss) -64.9M USD +17.5%
Nonoperating Income (Expense) 16.5M USD +51.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -48.4M USD +28.6%
Income Tax Expense (Benefit) 163K USD -62.4%
Net Income (Loss) Attributable to Parent -48.6M USD +28.8%
Earnings Per Share, Basic 0.18 USD/shares +30.3%
Earnings Per Share, Diluted 0.18 USD/shares +30.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 77.2M USD -43.1%
Accounts Receivable, after Allowance for Credit Loss, Current 82K USD -67.8%
Assets, Current 107M USD -36.2%
Property, Plant and Equipment, Net 7.01M USD -61.5%
Operating Lease, Right-of-Use Asset 5.01M USD +51.1%
Other Assets, Noncurrent 660K USD -39.6%
Assets 125M USD -34.6%
Accounts Payable, Current 11.3M USD -2.84%
Contract with Customer, Liability, Current 4.65M USD -75.6%
Liabilities, Current 27.8M USD -39.8%
Contract with Customer, Liability, Noncurrent 2.62M USD -91.4%
Operating Lease, Liability, Noncurrent 3.39M USD +105%
Other Liabilities, Noncurrent 5.83M USD +69.4%
Liabilities 39M USD -50.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.22M USD +0.25%
Retained Earnings (Accumulated Deficit) -374M USD -14.9%
Stockholders' Equity Attributable to Parent 86.1M USD -23.4%
Liabilities and Equity 125M USD -34.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -24.2M USD -748%
Net Cash Provided by (Used in) Financing Activities -135K USD +81.6%
Net Cash Provided by (Used in) Investing Activities -116K USD +57.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.86M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 77.4M USD -43.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1K USD
Deferred Tax Assets, Valuation Allowance 89.3M USD +35.8%
Deferred Tax Assets, Gross 94.4M USD +34.5%
Operating Lease, Liability 4.9M USD +48.5%
Payments to Acquire Property, Plant, and Equipment 116K USD -57.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -48.6M USD +29.9%
Lessee, Operating Lease, Liability, to be Paid 5.85M USD +44.1%
Property, Plant and Equipment, Gross 16.7M USD -38.4%
Operating Lease, Liability, Current 1.51M USD -6.75%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.63M USD +23.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.66M USD +5.41%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +250%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 412K USD +565%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.35M USD +15.1%
Deferred Tax Assets, Operating Loss Carryforwards 87.4M USD +32.1%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.21M USD
Additional Paid in Capital 467M USD +5.02%
Depreciation, Depletion and Amortization 640K USD -30.5%
Deferred Tax Assets, Net of Valuation Allowance 5.05M USD +15.3%
Share-based Payment Arrangement, Expense 1.2M USD -34.1%
Interest Expense 197K USD -65.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%